| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.29 | 2e-12 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-12 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.26 | 1e-11 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-11 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-10 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.24 | 5e-09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |